GINC Technology
Research & IP · South Africa

Afrigen Biologics

Hosts the WHO mRNA technology transfer hub, developing mRNA vaccine manufacturing processes for transfer to producers in low and middle-income countries.

Headquarters
Cape Town, South Africa · Africa
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2014
Ownership
Start-up
Website
afrigen.co.za
Relevance
Very low at its strongest, in Biomanufacturing

In 2 capabilities

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. BiomanufacturingVery low

    Biotechnology & Health Technologies · Research · listed #43 of 50

    Hosts the WHO mRNA technology transfer hub, developing mRNA vaccine manufacturing processes for transfer to producers in low and middle-income countries.

    Relevance: WHO mRNA hub host, early-stage

    Source · who.int

  2. Advanced Therapeutics, Vaccines & Medical CountermeasuresVery low

    Biotechnology & Health Technologies · Research · listed #44 of 50

    Hosts the WHO/MPP mRNA technology transfer hub; it independently reproduced an mRNA COVID-19 vaccine and trains manufacturers from more than 15 low- and middle-income countries.

    Relevance: WHO mRNA hub host, early-stage

    Source · who.int